CXCR4 and breast cancer: We proceeded to simultaneously assess the potential apoptotic activity of all these compounds (Figure 1), including AMD3100, IT1t, MSX-122, TIQ-15 and compounds 1-8 in MDA-MB-231 cells versus the CXCR4 negative MDA-MB-468 breast cancer cells.